The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Gout patients on peritoneal dialysis (PD) require lower allopurinol doses. PD removes over 50% of oxypurinol and urate, necessitating dose adjustments for effective gout management.
Area Of Science
- Nephrology
- Pharmacology
- Gout Management
Background
- Gout is prevalent in advanced kidney disease.
- Allopurinol is a common urate-lowering therapy, metabolized to oxypurinol.
- Oxypurinol is primarily renally excreted, with poorly understood pharmacokinetics in kidney failure.
Purpose Of The Study
- To characterize oxypurinol and urate elimination in patients with gout undergoing peritoneal dialysis.
- To determine the impact of peritoneal dialysis on oxypurinol pharmacokinetics.
Main Methods
- Calculated oxypurinol and urate clearances (kidney and peritoneal) from plasma, urine, and dialysate concentrations.
- Determined oxypurinol steady-state oral clearance (CL/F) and elimination half-life.
Main Results
- Peritoneal dialysis significantly contributes to oxypurinol and urate elimination, accounting for over 50% of their clearances.
- Oxypurinol and urate are effectively removed by peritoneal dialysis.
Conclusions
- Patients with gout on peritoneal dialysis require approximately 50%-60% lower allopurinol doses compared to those with normal kidney function.
- Dose reduction is crucial for safe and effective urate-lowering therapy in this population.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...